Consistent with this, using data generated by Beltran et al. 49 we found TSPAN1 and Slug are co-amplified in 28% and 37% of neuroendocrine prostate cancer tumours respectively (Supplementary Table 4). Here, SNAI2 is linked to neoplasm.